Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine alpha 4 beta 2 Receptor Antagonist for the Treatment of Depression

导出原文传递

翻译打印收藏纠错

作者： Nirogi, Ramakrishna ^[1] ; Mohammed, Abdul Rasheed ; Shinde, Anil K. ; Ravella, Srinivasa Rao ; Bogaraju, Narsimha ; Subramanian, Ramkumar ; Mekala, Venkat Reddy ; Palacharla, Raghava Choudary ; Muddana, Nageswararao ; Thentu, Jagadeesh Babu ; Bhyrapuneni, Gopinadh ; Abraham, Renny ; Jasti, Venkat

作者单位： Suven Life Sci Ltd, Discovery Res, Hyderabad 500034, India ^[1]

发布时间 2021-09-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of Medicinal Chemistry

2020年63卷6期

2833-2853页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine alpha 4 beta 2 Receptor Antagonist for the Treatment of Depression

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Discovery and Development of 3-(6-Chloropyridine-3-yloxymethyl)-2-azabicyclo[3.1.0]hexane Hydrochloride (SUVN-911): A Novel, Potent, Selective, and Orally Active Neuronal Nicotinic Acetylcholine alpha 4 beta 2 Receptor Antagonist for the Treatment of Depression

Journal of Medicinal Chemistry

相似文献

Journal of Medicinal Chemistry

相关期刊

检索历史清除